Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Arthritis, Rheumatoid 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Graft vs Host Disease 6Leukemia 5Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Lymphoma, Follicular 4Leukemia, Myeloid, Acute 4Myelodysplastic Syndromes 3Lymphoma 3Psoriasis 2Neoplasms 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Burkitt Lymphoma 2Urinary Bladder Neoplasms 1Stomatitis 1Recurrence 1Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Osteosarcoma 1Neutropenia 1Mycosis Fungoides 1Multiple Myeloma 1Meningeal Neoplasms 1Meningeal Carcinomatosis 1Lymphoproliferative Disorders 1

Interventions

XENP 1595 2birtamimab 1UE2343 1Rosiglitazone 1Propofol 1Positron-Emission Tomography 1Methotrexate 1Electroencephalography 1Donepezil 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Alzheimer Disease × Methotrexate × Clear all
NCT04571697 2025-04-27

A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy

Janssen Research & Development, LLC

Completed
34,647 enrolled

Alzheimer Disease, Dementia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡